Welcome to the Hope Bio Blog

By Jan Shultis, Ph.D. Earlier this year, a peer-reviewed piece on an FDA-authorized clinical trial in Parkinson’s Disease was published by Wiley. Currently screening is underway for another Parkinson’s Disease trial, the seventh using Hope Bio’s cells to date, while detailed analysis continues on a completed Phase II trial that announced positive topline results. As we head into the fourth quarter of 2026, let’s take a look at what the Wiley piece says in plain language, wher

By Jan Shultis, Ph.D. Update! One of trials mentioned in this article now has published results. Click here to read the Wiley piece. Sugar Land, Texas 21 June 2021: In the months to come, Houston area biopharmaceutical company Hope Biosciences will culture more than 85 billion stem cells for the fight against Parkinson’s Disease, to be used in two FDA-authorized Phase II clinical trials. Hope Biosciences cultures pure mesenchymal stem cells, a type of stem cell found in adult

By Jan Shultis, Ph.D. Update! The trial announced in this article now has published results. Click here to read the Wiley piece. Sugar Land, Texas 28 April 2021: In the months to come, Houston area biopharmaceutical company Hope Biosciences will send more than 24 billion stem cells to the fight against Parkinson’s Disease. Hope Biosciences cultures pure mesenchymal stem cells, a type of stem cell found in adult fat, to develop cell-based therapeutics for a variety of indicat